Member of The Scientific Advisory Board @ (January 2018 - February 2024)
Founder and CEO @ (October 2022 - Present)
Advisor @ (April 2023 - Present)
Adjunct Professor @ (September 2023 - Present)
Adjunct Professor, Leder School of Business @ (January 2019 - Present)
Past Chair, Board of Governors @ (October 2024 - October 2025)
Chairperson, Board of Governors @ (September 2021 - October 2024)
Board of Governors, Vice-Chair @ (January 2020 - September 2021)
Equip Partner @ (January 2010 - January 2024)
Executive Vice President, Research @ (January 2020 - January 2022)
Executive Vice President Corporate Development @ (January 2017 - January 2020)
Vice President, Clinical Affairs @ (January 2013 - January 2017)
Board Member @ biovialife (January 2013 - January 2019)
Board Member @ (January 2013 - January 2016)
Vice President, Clinical Affairs @ Isotechnika Pharma Inc. (January 2011 - January 2013)
Sr. Director, Clinical Affairs @ Isotechnika Pharma Inc. (January 2006 - January 2011)
Director, Clinical Affairs @ Isotechnika Pharma Inc. (January 2002 - January 2006)
Research Epidemiologist and Nephrology Nurse Clinician @ (January 1991 - January 2002)
Founder and Moderator of RenalPro @ (January 1994 - January 1998)
Registered Nurse, Nephrology @ (January 1988 - January 1991)
Robert Huizinga Education
Regent University
Doctor of Philosophy - PhD (Organizational Leadership)
University of Alberta
Master of Science - MS (Clinical Epidemiology)
University of Alberta
Registered Nurse - RN
Robert Huizinga Skills
Strategic Leadership
Leadership Development
Cross-functional Team Leadership
Public Speaking
Clinical Development
Biotechnology
Drug Development
Clinical Research
Pharmaceutical Industry
Leadership
CRO
Strategy
Protocol
Lifesciences
Life Sciences
Transplant
Diabetes
Clinical Operations
Clinical Trials
ICH-GCP
Healthcare
GCP
Infectious Diseases
CTMS
Regulatory Affairs
Statistics
Commercialization
Biopharmaceuticals
FDA
Regulatory Submissions
Nephrology
Guest Lecturing
Data Management
Medical Devices
Neurology
Epidemiology
Medical Writing
Corporate Governance
Corporate Development
Clinical Monitoring
Product Lifecycle Management
EDC
Sop
Cross-cultural Teams
Transplantation
Good Clinical Practice (GCP)
CRO Management
Executive Leadership
Pharmaceutical Consulting
Cross Cultural Teams
Cross Functional Team Leadership
Oracle Clinical
Ich Gcp
Dermatology
Clinical Trial Management
Product Life Cycle Management
Good Clinical Practice Gcp
Cancer
Good Clinical Practice
Robert Huizinga Summary
Robert Huizinga, is currently a Interim Chief Executive Officer at Kane Biotech Inc.. Robert Huizinga brings experience from previous roles at Kane Biotech Inc., Reformation Consulting Services Inc. and Avivo Biomedical Inc.. Robert Huizinga holds a Doctor of Philosophy - PhD in Organizational Leadership @ Regent University. With a robust skill set that includes Strategic Leadership, Leadership Development, Cross-functional Team Leadership, Public Speaking, Clinical Development and more. Robert Huizinga has 5 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Robert Huizinga?
Find contact details for 700 million professionals.